Alexander Spira

Alexander Spira, MD, PhD, FACP

Virginia Cancer Specialists Research Institute

Topic Presenter

Biography

Dr. Alexander Spira earned his medical degree from the New York University School of Medicine. He then went on to complete his internship and residency at the Hospital of the University of Pennsylvania, and his medical oncology fellowship at Johns Hopkins Hospital. During his training, Dr. Spira was granted many awards and honors, and he completed several specialized fellowship programs. Among these honors were the National Institutes of Health Medical Scientist Training Program Fellowship (1990-1997), Merck Corporation Scholarship (1995-1995), Pediatric AIDS Foundation Fellowship (1993- 1995) and Harvard University Scholarship (1987-1990). Dr. Spira has also received his PhD from the New York School of Arts and Sciences. As Director of the Virginia Cancer Specialists Research Institute and the Phase I Trial Program, Dr. Spira is actively involved in advancing medicine and offering targeted treatment options for patients. Although his research interests are numerous, Dr. Spira particularly enjoys studying immunotherapy, personalized medicine, GI, thoracic and lung cancer and sarcomas. Dr. Spira is Chief Scientific Officer of NEXT Oncology, as well as Co-Chair of the US Oncology Thoracic Oncology Committee, Chair of the US Oncology Research Executive Committee, and member of the US Oncology National Policy Board Executive Committee. Dr. Spira is a faculty member at Johns Hopkins School of Medicine and serves as Assistant Professor of Oncology. Throughout his career, Dr. Spira has been recognized as a Top Doctor in Northern Virginia Magazine and Washingtonian magazine for multiple years. In 2014, he received the prestigious “Castle Connolly America’s Top Doctor” award. In his spare time, Dr. Spira enjoys spending time with his family, coaching children’s sports, cycling, and cheering on his favorite New York sports teams.

Financial Disclosure

incyte

Consultant

Advisor

Amgen

Consultant

Advisor

Novartis

Consultant

Advisor

Mirati Therapeutics

Advisor

Consultant

Gritstone Oncology

Consultant

Advisor

Jazz Pharmaceuticals

Consultant

Advisor

Takeda

Consultant

Advisor

Janssen Research & Development

Advisor

Consultant

Mersana

Consultant

Advisor

Gritstone Bio

Consultant

Advisor

Daiichi Sankyo/Astra Zeneca

Advisor

Consultant

Regeneron

Advisor

Consultant

Lilly

Consultant

Advisor

Black Diamond Therapeutics

Advisor

Consultant

Sanofi

Consultant

Advisor

ArriVent Biopharma

Advisor

Consultant

Synthekine

Consultant

Advisor

GSK

Consultant

Advisor

Revolution Medicines

Consultant

Advisor

normunity

Consultant

Advisor

myricx

Consultant

Advisor

Summit Therapeutics

Consultant

Advisor

Tempus

Consultant

Advisor

AstraZeneca/MedImmune

Consultant

Advisor

Merck

Consultant

Advisor

Bristol-Myers Squibb

Consultant

Advisor

Blueprint Medicines

Consultant

Advisor

Verastem

Consultant

Advisor

NEXT Oncology Virginia

Employee

IQVIA

Ownership Interest